Quel est le prix pour Steep Hill Inc. (STPH)

Le prix pour Steep Hill Inc. (STPH) est $0.23955051

Quelle est la capitalisation boursière pour Steep Hill Inc. (STPH)

La capitalisation boursière pour Steep Hill Inc. (STPH) est $645.93K

Steep Hill Inc. (STPH) Ratio P/B

Established in Toronto, Canada, in 2008, Steep Hill Inc. operates as a leading science and technology firm dedicated to the cannabis sector. The company delivers an extensive range of services throughout Canada and the United States, including sophisticated laboratory analysis, thorough quality assurance, and insightful data analytics. Its testing capabilities cover a broad spectrum, assessing cannabinoids, terpenes, pesticides, mycotoxins, heavy metals, and residual solvents. Additionally, Steep Hill conducts microbial examinations, foreign material screenings, and evaluates moisture levels, water activity, vitamin E acetate presence, and product uniformity, alongside comprehensive hemp assessments. Beyond its testing facilities, the organization offers specialized consulting regarding analytical methodologies, cannabis industry regulations, specific testing protocols, laboratory information management systems (LIMS), and overarching product integrity and safety. The entity rebranded to Steep Hill Inc. in February 2022, having previously operated as Cannabis Clonal Corporation.

Année	Ratio P/B	Changez
Pas assez de données pour les dates fournies.

Année

Ratio P/B

Changez

Pas assez de données pour les dates fournies.

Entreprise	Ratio P/B	Différence de Ratio P/B	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.7207	-	IN

Entreprise

Ratio P/B

Différence de Ratio P/B

Pays